Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7989644 | Electroluminescent device Disclosed are electroluminescent devices that comprise organic layers that contain dibenzofuran compounds. The compounds are suitable components of, for example, blue-emitting, durable, organo-electroluminescent layers. The electroluminescent devices may be employed... | 08/02/2011 |
| 7417157 | Hexahydrodibenzofuran derivatives Disclosed are hexahydrodibenzofuran compounds of formula I, the preparation thereof, the use thereof as components in liquid-crystalline media, and to electro-optical display elements which contain the liquid-crystalline me... | 08/26/2008 |
| 7358364 | Substituted carboxylic acids The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds inclu... | 04/15/2008 |
| 7288543 | Opioid receptor antagonists A compound of the formula (I) (I) wherein the variables X1 to X6, Ra, Rb, R1 to R7 including R3′, E, p, j, y, z, A, B and C are as described or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the trea... | 10/30/2007 |
| 7244516 | Organic electroluminescence device An organic electroluminescence device including an organic layer having a light emission region and being disposed between an anode and a cathode is provided. The organic layer contains, as an organic light-emitting material, a compound represented by the following ... | 07/17/2007 |
| 7196089 | EPreceptor antagonists Compounds of formula (I): wherein: R2 is H or an optionally substituted C1-4 alkyl group; Y is either —(CH2)n—X—, where n is 1 or 2 and X is O, S, S(═O), S(═O... | 03/27/2007 |
| 7186752 | Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them N-(imino)amines and their preparation and their use as NO synthase inhibitors and selective or non-selective traps for a reactive oxygen species. ... | 03/06/2007 |
| 7119214 | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): | 10/10/2006 |
| 7026478 | Iron catalyzed cross coupling reactions of aromatic compounds A process for the production of compounds Ar—R1 by means of a cross-coupling reaction of an organometallic reagent R1-M with an aromatic or heteroaromatic substrate Ar—X catalyzed by one or several iron salts or iron complexes as catalysts ... | 04/11/2006 |
| 6864254 | Inhibitor for 20-hete-yielding enzyme An inhibitor for 20-hydroxyeicosatetraenoic acid production which comprises as the active ingredient a specific hydroxyformamidine derivative or a pharmacologically acceptable salt thereof. It is useful especially as a remedy for kidney diseases, cerebrovascular dis... | 03/08/2005 |
| 6800656 | Tricyclic compounds and method of treating herpes virus The present invention provides a compound of the formula and pharmaceutically acceptable salts having useful antiviral activity against viruses of the herpes family. Wherein: X=O, (CH2)m, S, ... | 10/05/2004 |
| 6720431 | Methods and apparatus for separating and detecting specific polyhalogenated diaromatic hydrocarbons Sample processing methods that utilize a graphitised carbon matrix are useful for determining the relative amounts polyhalogenated biphenyls (PHBs), polyhalogenated dibenzofurans (PHDFs), and polyhalogenated dibenzo-p-dioxins (PHDDs) in a mixture of polyhalogenated ... | 04/13/2004 |
| 6710089 | Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atheroscle... | 03/23/2004 |
| 6696573 | Processes for the preparation of tricyclic amino alcohol derivatives A process for the preparation of tricyclic amino alcohol derivatives including 2-[N-[2-(9H-carbazol-2-yloxy)ethyl]]amino-1-[(3-methylsulfonylamino)phenyl ]ethanol useful in the treatment of diabetes, obesity, hyperlipidemia and so on; and intermediate... | 02/24/2004 |
| 6653346 | Cytoprotective benzofuran derivatives Cytoprotective compounds, many of which are benzofuran derivatives are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders charact... | 11/25/2003 |
| 6495701 | Method for manufacturing tricyclic amino alcohol derivatives The present invention is directed to processes for the preparation of a compound useful for treating diabetes, obesity, hyperlipidemia and the like, which compound is represented by the formula (1): ##STR1## wherein R1 represents a lower alkyl ... | 12/17/2002 |
| 6448295 | Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 09/10/2002 |
| 6350885 | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases Tricyclic heteroaromatic compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, collagenase-3, and str... | 02/26/2002 |
| 6294674 | Dibenzofuran sulfonamide matrix metalloproteinase inhibitors The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds. ##STR1## wherein Q is an un-natural amino acid. More particurlarly, the present ... | 09/25/2001 |
| 6172104 | Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof Methods of treating Pneumocystis carinii pneumonia comprise administering a therapeutically effective amount of a dicationic dibenzofuran compound described by Formula (I). Methods of treating Pneumocystis carinii pneumonia also comprise administering a t... | 01/09/2001 |
| 6172099 | Tricyclic compounds having saturated rings and medicinal compositions containing the same Compounds represented by general formula (I) or their salts, having 댣 -adrenoceptor agonism and being efficacious when employed in drugs for treating and preventing diabetes, obesity, hyperlipemia, etc. wherein R represents hydrogen or m... | 01/09/2001 |
| 6037479 | Chiral diarsine compounds Novel, chiral diarsine compounds, which are present in the (R)- or (S)- or (rac)-form, of the formula ##STR1## wherein R signifies an optionally substituted aryl from the group of phenyI, naphthyl, furyl and thienyl; C3-8 -cycloalkyl or C | 03/14/2000 |
| 6037361 | Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases Fluorinated butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase)... | 03/14/2000 |
| 6020366 | Butyric acid matrix metalloproteinase inhibitors Compounds of the formula ##STR1## wherein R1 and R2 include hydrogen, alkyl, substituted alkyl, halo, and arylalkyl; R3 is hydroxy, alkoxy, or hydroxyamino; X is O, S, or NOH; and R4 and R5 inclu... | 02/01/2000 |
| 5942532 | 2-substituted phenyl-benzimidazole antibacterial agents The invention relates to benzimidazole antibacterial compounds of the Formula I: ##STR1## as described herein, pharmaceutical compositions containing the compounds, and methods for their production and use. These compounds are effective in inhib... | 08/24/1999 |
| 5935992 | Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta6,!benzofurans The invention provides substituted-2-amino-1,2,3,4-tetrahydrodibenzofurans and 2-aminocycloheptab!benzo-furans useful as 5-HT1F agonists.... | 08/10/1999 |
| 5869662 | Photochromic benzopyran compounds Benzopyran compounds represented by the formulas: ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are selected from hydrogen, a stab... | 02/09/1999 |
| 5858995 | Benzofuran derivatives useful as inhibitors of bone resorption This invention relates to a novel heterocyclic compound represented by formula (I), wherein each symbol is as defined in the specification and a pharmaceutically acceptable salt thereof which are the inhibitors of bone resorption and bone metabolism, to p... | 01/12/1999 |
| 5846995 | Substituted 1, 2, 3, 4-tetrahydro-2-dibenzofuranamines and 2-amino-cyclohepta (6, 7-B) Benzofurans The invention provides substituted-2-amino-1,2,3,4-tetrahydrodibenzofurans and 2-aminocycloheptab!benzo-furans useful as 5-HT1F agonists.... | 12/08/1998 |
| 5840927 | Sesquiterpene compounds Novel anti-microbial sesquiterpene compounds isolated from the fruit bodies of Roseofomes subflexibilis (Hounen-take) having the general formula ##STR1##... | 11/24/1998 |
| 5840980 | Diamine compounds and electrophotographic photoreceptor A diamine compound of the following formula (1): ##STR1## wherein R1 is a hydrogen atom, a lower alkyl group or a lower alkoxy group, each of A1, A2 and A3 which are independent of one another, is a substit... | 11/24/1998 |
| 5739360 | Intermediates for the synthesis of bisphosphine compounds The invention relates to novel bisphosphonates and to processes for their preparation and for their resolution into the enantiomers. The bisphosphonates according to the invention are valuable intermediates for the preparation of bisphosphine compounds, e... | 04/14/1998 |
| 5716986 | Oxaindene derivatives and process for the preparation thereof This invention relates to new oxaindene derivatives, a process for the preparation thereof and pharmaceutical compositions comprising the same. The compounds according to the invention are characterized by the general formula (1) ##STR1## wherein R | 02/10/1998 |
| 5665764 | Tricyclic inhibitors of matrix metalloproteinases Tricyclic compounds are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treat... | 09/09/1997 |
| 5631401 | Inhibitors of protein farnesyltransferase and squalene synthase The present invention provides a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof, which are useful in inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting de novo squale... | 05/20/1997 |
| 5543422 | Heterocyclic amines Heterocyclic amines of the formula Ar-X-A-NR1 R2 wherein Ar is a bicyclic or tricyclic aromatic group which is unsubstituted or which bears one or more substituents selected from halo, nitro and cyano groups and alkyl and alkoxy groups ea... | 08/06/1996 |
| 5541333 | Carbazole derivatives Novel tethered hapten intermediates and related conjugates based on carbazole and/or dibenzofuran, as well as methods for making and using such conjugates. Haptens based on the above core structures may be substituted at any position on the aromatic rings... | 07/30/1996 |
| 5516790 | Synthesis and application of alkyl-substituted dibenzofurans as antitumorigenic agents Provided is a method of inhibiting estrogen activity by administering a biologically active amount of a substituted dibenzofuran or substituted dibenzodioxin.... | 05/14/1996 |
| 5496849 | Sulfonic acid derivative and its pharmaceutical application The present invention discloses sulfonamide derivative represented by the following general formula: ##STR1## [wherein, R1 is (i) --COOR2 (where, R2 is (1) hydrogen, (2) a pharmacologically acceptable cation, or (3) a... | 03/05/1996 |
| 5489603 | Guanidine derivatives, their production and insecticides An insecticidal composition containing a guanidine derivative of the formula: ##STR1## wherein R1 is an optionally substituted homocyclic or heterocyclic group, n is 0 or 1, R2 is a hydrogen atom or an optionally substitute... | 02/06/1996 |